CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of EUR 402.83 million. The enterprise value is 388.41 million.

Market Cap	402.83M
Enterprise Value	388.41M

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.82M

Valuation Ratios

The trailing PE ratio is 28.73 and the forward PE ratio is 24.98.

PE Ratio	28.73
Forward PE	24.98
PS Ratio	5.84
PB Ratio	5.21
P/TBV Ratio	6.92
P/FCF Ratio	24.97
P/OCF Ratio	23.18
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.78, with an EV/FCF ratio of 24.08.

EV / Earnings	27.70
EV / Sales	5.74
EV / EBITDA	18.78
EV / EBIT	21.90
EV / FCF	24.08

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.03.

Current Ratio	3.69
Quick Ratio	2.68
Debt / Equity	0.03
Debt / EBITDA	0.10
Debt / FCF	0.13
Interest Coverage	40.27

Financial Efficiency

Return on equity (ROE) is 19.05% and return on invested capital (ROIC) is 14.61%.

Return on Equity (ROE)	19.05%
Return on Assets (ROA)	12.14%
Return on Invested Capital (ROIC)	14.61%
Return on Capital Employed (ROCE)	21.19%
Revenue Per Employee	302,363
Profits Per Employee	61,496
Employee Count	219
Asset Turnover	0.74
Inventory Turnover	1.95

Taxes

In the past 12 months, CellaVision AB has paid 3.59 million in taxes.

Income Tax	3.59M
Effective Tax Rate	20.41%

Stock Price Statistics

The stock price has decreased by -27.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.19%
50-Day Moving Average	16.88
200-Day Moving Average	18.65
Relative Strength Index (RSI)	36.82
Average Volume (20 Days)	398

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of EUR 68.94 million and earned 14.02 million in profits. Earnings per share was 0.59.

Revenue	68.94M
Gross Profit	47.21M
Operating Income	18.06M
Pretax Income	17.62M
Net Income	14.02M
EBITDA	19.95M
EBIT	18.06M
Earnings Per Share (EPS)	0.59

Full Income Statement

Balance Sheet

The company has 16.80 million in cash and 2.12 million in debt, giving a net cash position of 14.69 million.

Cash & Cash Equivalents	16.80M
Total Debt	2.12M
Net Cash	14.69M
Net Cash Per Share	n/a
Equity (Book Value)	77.29M
Book Value Per Share	3.24
Working Capital	29.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.37 million and capital expenditures -1.24 million, giving a free cash flow of 16.13 million.

Operating Cash Flow	17.37M
Capital Expenditures	-1.24M
Free Cash Flow	16.13M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.48%, with operating and profit margins of 26.20% and 20.34%.

Gross Margin	68.48%
Operating Margin	26.20%
Pretax Margin	25.55%
Profit Margin	20.34%
EBITDA Margin	28.94%
EBIT Margin	26.20%
FCF Margin	23.40%

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 1.42%.

Dividend Per Share	0.23
Dividend Yield	1.42%
Dividend Growth (YoY)	18.98%
Years of Dividend Growth	n/a
Payout Ratio	39.14%
Buyback Yield	n/a
Shareholder Yield	1.42%
Earnings Yield	3.48%
FCF Yield	4.00%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7